Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. junior Avg
|
New words:
AAHI, ACTG, admission, agonist, Alaska, Ave, Bankr, bankrupt, binomial, Bloomberg, bore, CAMT, carcinogenic, CG, Chapter, circumstance, conducive, contemporaneously, contrary, coupon, cyberthreat, Distinguishing, dramatically, DRJ, DSCSA, edge, excise, extinguished, extinguishment, Exyte, fault, FDORA, Ferring, Fort, Fousek, freestanding, FSMC, geopolitical, gu, HCW, hookworm, illegitimate, imidazoquinolinone, impasse, IPC, kick, LadRx, latent, lattice, LMIC, lot, Lynch, malaria, misrepresented, mode, multivalent, mutable, mutagenic, NEJM, numerator, organizational, parking, PDMA, PDUFA, PHI, pichia, Poison, preempted, prejudgment, premarket, presumption, PSA, radiosurgery, rechallenge, redeem, registry, replevin, reply, reproduction, resiquimod, Schuyler, searchable, sequester, shortfall, Slight, specialist, spoilage, successor, Tex, text, theory, tied, tiered, trace, transcription, tree, Ukraine, unconditionally, unexercisable, unnecessary, upstate, varicella, violative, wholesale, Xencor, zoster
Removed:
acutely, African, aggressive, albumin, appellate, appointment, aspect, Chase, Circuit, contrast, cyber, decided, died, expired, Fox, half, harnessing, infusion, integration, intraperiod, mediated, merged, opened, optimized, participated, path, peripheral, preceding, principle, proven, Pty, ratably, Ratification, reacquiring, simplifying, simultaneously, stimulation, strike, Sudunagunta, surface, unearned, unopposed, unspecified, Vice
Filing tables
Filing exhibits
Related press release
IBRX similar filings
Filing view
External links
Exhibit 32.1
CERTIFICATION OF CHIEF EXECUTIVE OFFICER
PURSUANT TO 18 U.S.C. § 1350, AS ADOPTED
PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
Pursuant to 18 U.S.C. § 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, I, Richard Adcock, the chief executive officer of ImmunityBio, Inc. (the “Company”), hereby certify, that, to the best of my knowledge:
i.the Annual Report of the Company on Form 10-K for the year ended December 31, 2022 (the “Report”), fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
ii.the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
Date: March 1, 2023 | By: | /s/ Richard Adcock | ||||||
Richard Adcock | ||||||||
Chief Executive Officer and President | ||||||||
(Principal Executive Officer) |